Your browser doesn't support javascript.
loading
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Ashton, Nicholas J; Nevado-Holgado, Alejo J; Barber, Imelda S; Lynham, Steven; Gupta, Veer; Chatterjee, Pratishtha; Goozee, Kathryn; Hone, Eugene; Pedrini, Steve; Blennow, Kaj; Schöll, Michael; Zetterberg, Henrik; Ellis, Kathryn A; Bush, Ashley I; Rowe, Christopher C; Villemagne, Victor L; Ames, David; Masters, Colin L; Aarsland, Dag; Powell, John; Lovestone, Simon; Martins, Ralph; Hye, Abdul.
Afiliação
  • Ashton NJ; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.
  • Nevado-Holgado AJ; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK.
  • Barber IS; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Lynham S; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Gupta V; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Chatterjee P; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Goozee K; Proteomics Core Facility, James Black Centre, King's College, London, UK.
  • Hone E; School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia.
  • Pedrini S; Cooperative Research Centre for Mental Health, Carlton South, VIC, Australia.
  • Blennow K; School of Medicine, Faculty of Health, Deakin University, 3220 VIC, Australia.
  • Schöll M; School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia.
  • Zetterberg H; KaRa Institute of Neurological Diseases, Macquarie Park, NSW, Australia.
  • Ellis KA; Department of Biomedical Sciences, Macquarie University, 2109, NSW, Australia.
  • Bush AI; KaRa Institute of Neurological Diseases, Macquarie Park, NSW, Australia.
  • Rowe CC; Department of Biomedical Sciences, Macquarie University, 2109, NSW, Australia.
  • Villemagne VL; Clinical Research Department, Anglicare, Sydney, NSW, Australia.
  • Ames D; School of Psychiatry and Clinical Neurosciences, University of Western Australia, WA, Australia.
  • Masters CL; School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia.
  • Aarsland D; Cooperative Research Centre for Mental Health, Carlton South, VIC, Australia.
  • Powell J; School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia.
  • Lovestone S; Cooperative Research Centre for Mental Health, Carlton South, VIC, Australia.
  • Martins R; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Hye A; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Sci Adv ; 5(2): eaau7220, 2019 02.
Article em En | MEDLINE | ID: mdl-30775436
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Peptídeos beta-Amiloides / Proteômica / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Peptídeos beta-Amiloides / Proteômica / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article